DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Endroit courant :
> This Story

Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment



Business Affairs Homepage

Siemens Healthineers shares surge after Frankfurt Stock Exchange IPO The stock closed at 30 euros on Friday

FDA warns duodenoscope makers about failure to comply with requirements Reprocessing issues resurface for Olympus, Fujifilm and Pentax

Cigna to purchase Express Scripts for $52 billion The latest in a string of insurance-pharma M&A activity

Onkos Surgical and 3D Systems sign four-year business agreement Personalizing musculoskeletal cancer treatment

Samsung and Philips partner to broaden the connected health ecosystems The companies' platforms will be connected

Canon acquires cardiac IT manufacturer Fysicon Obtains wide portfolio of monitoring systems sold globally

Verasonics files suit against Supersonic Imagine Claims software beamforming architecture infringes patent

Northwell Health touts Philips collab for ICU and ED improvements at HIMSS Experienced 20 percent drop in ICU mortality rate

Philips inks deal with Hologic for mammography equipment Will integrate with broader portfolio for 'a complete set of innovative diagnostic imaging systems'

Siemens now planning smaller Healthineers IPO The offer puts a price of 31 billion euros on the division, previously estimated around 35 billion

CVS takes Aetna in $69 billion deal

par Thomas Dworetzky , Contributing Reporter
“CVS Health, the largest pharmacy health care provider in the U.S., has agreed to acquire Aetna,” Aetna chairman and CEO Mark Bertolini announced in a statement Sunday.

He reassured members that the deal “will have no immediate effect on your benefits,” adding that, “we will use CVS Health’s footprint of more than 9,700 retail stores and 1,100 in-store clinics to establish entirely new community health hubs dedicated to improving consumer well-being and answering questions about health, prescription drugs and health care benefits.”

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras

“We think of it as creating a new front door to health care in America,” said CVS Health’s chief executive, Larry J. Merlo, according to the The New York Times.

The deal will give Aetna shareholders $145.00 per share in cash and 0.8378 CVS Health shares for each Aetna share, which values Aetna at about $207 per share.

Aetna stated that the deal would fill “an unmet need" in the current health care system “increasing numbers of consumers are taking on more and more responsibility for paying for their health care as the burden of costs is being shifted to them,” according to the company.

The deal, if it passes regulatory hurdles, will offer consumers a more “integrated” experience, claims the company.

“We are obviously going to get some scrutiny,” said Bertolini according to Bloomberg News. “We are prepared to deal with whatever comes along to make this work.”

It could save the combined firms around $750 million.

It will also allow a vertical integration that some say is a response to fears surrounding Amazon's potential to disrupt the market.

Such deals have usually won approval in the past, but that may not be true going forward – as evidenced by the suit by the DOJ to block a similar vertical deal between AT&T and Time Warner.

“Most vertical deals don’t raise antitrust concerns, and the ones that do generally get approval to close with an agreement containing behavioral conditions,” according to Jennifer Rie, a Bloomberg Intelligence analyst. “But the Justice Department appears to be rejecting this kind of remedy, given its approach to the AT&T-Time Warner deal.”

Michael Newshel, an analyst at Evercore ISI, told Bloomberg that Aetna could be required to unload its Medicare-related drug business either in part or completely to seal the deal, advising that it “would definitely be scrutinized, but ultimately we still see a path for it to get through.”
  Pages: 1 - 2 >>

Business Affairs Homepage

You Must Be Logged In To Post A Comment

Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2018, Inc.